Makoto Akaike
Overview
Explore the profile of Makoto Akaike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
985
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamoto N, Oshima T, Yoshihara K, Aoyama T, Hayashi T, Yamada T, et al.
Oncol Lett
. 2017 May;
13(5):3958-3966.
PMID: 28521493
The insulin-like growth factors (IGF) system is involved in tumor proliferation, invasion and metastasis in cancer. The current study investigated the association of , and receptor (), IGF binding proteins...
2.
Numata K, Morinaga S, Katayama Y, Sawazaki S, Numata M, Godai T, et al.
Anticancer Res
. 2016 Apr;
36(5):2467-74.
PMID: 27127159
Aim: The aim of this study was to confirm the predictive/prognostic value of the preadjuvant Glasgow Prognostic Score (GPS) and carbohydrate antigen (CA) 19-9 level in pancreatic cancer patients receiving...
3.
Numata K, Oshima T, Sakamaki K, Yoshihara K, Aoyama T, Hayashi T, et al.
J Cancer Res Clin Oncol
. 2015 Sep;
142(2):415-22.
PMID: 26337161
Purpose: Curative resection and adjuvant chemotherapy is the standard treatment for Stage II/III gastric cancer, and S-1 is widely used for adjuvant chemotherapy. The type 1 insulin-like growth factor receptor...
4.
Wada H, Shiozawa M, Katayama K, Okamoto N, Miyagi Y, Rino Y, et al.
J Gastroenterol
. 2015 Mar;
50(7):727-34.
PMID: 25725617
Background: In this study we examined whether histopathological findings, specifically lymphatic vessel invasion identified by an anti-human podoplanin antibody, and several other factors are associated with lymph node metastasis in...
5.
Aoyama T, Katayama Y, Murakawa M, Asari M, Kanazawa A, Higuchi A, et al.
Cancer Chemother Pharmacol
. 2014 Oct;
74(6):1235-40.
PMID: 25297990
Background: The factors which affect the 6-month continuation of adjuvant chemotherapy with S-1 have not been fully evaluated in pancreatic cancer. The objective of this retrospective study was to clarify...
6.
Shimada Y, Hamaguchi T, Mizusawa J, Saito N, Kanemitsu Y, Takiguchi N, et al.
Eur J Cancer
. 2014 Jun;
50(13):2231-40.
PMID: 24958736
Background: NSABP C-06 demonstrated the non-inferiority of oral adjuvant uracil and tegafur plus leucovorin (UFT/LV) to weekly fluorouracil and folinate (5-FU/LV) with respect to disease-free survival (DFS) for stage II/III...
7.
Oshima T, Yoshihara K, Aoyama T, Hasegawa S, Sato T, Yamamoto N, et al.
Anticancer Res
. 2014 Apr;
34(5):2303-9.
PMID: 24778035
Inhibin-βA (INHBA), a ligand belonging to the transforming growth factor-β superfamily, is associated with cell proliferation in cancer. We studied the relations of INHBA gene expression to clinicopathological factors and...
8.
Yamada T, Oshima T, Yoshihara K, Sato T, Nozaki A, Shiozawa M, et al.
J Surg Oncol
. 2014 Apr;
109(8):836-40.
PMID: 24700475
Background And Objectives: Sushi repeat-containing protein X-linked 2 (SRPX2) was first described as a downstream target gene for E2A-HLA, which causes pro-B acute leukemia. SRPX2 is considered to promote cellular...
9.
Sato T, Oshima T, Yamamoto N, Yamada T, Hasegawa S, Yukawa N, et al.
J Surg Oncol
. 2013 Sep;
108(6):364-8.
PMID: 24018911
Purpose: Secreted protein acidic and rich in cysteine (SPARC) is one of the first known matricellular proteins that modulates interactions between cells and extracellular matrix. Recent studies investigated the clinical...
10.
Washimi K, Yokose T, Amitani Y, Nakamura M, Osanai S, Noda H, et al.
Pathol Int
. 2013 May;
63(4):220-5.
PMID: 23692423
Well-differentiated papillary mesothelioma (WDPM) is a distinct subtype of mesothelial tumor from diffuse malignant mesothelioma (DMM), with an uncertain malignant potential. The relationship between WDPM and DMM, with regard to...